Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

Asian Journal of Pharmaceutical Sciences is a prestigious open-access journal published by Shenyang Pharmaceutical University, dedicated to advancing research and developments in the field of pharmaceutical sciences. Since its inception in 2009, the journal has successfully converged a wealth of knowledge and innovation, demonstrating an impressive track record with its open access model adopted in 2013, ensuring global dissemination of crucial research findings. With an outstanding impact factor and consistently ranked in the Q1 category for both Pharmaceutical Science and Pharmacology in 2023, it ranks among the top journals in its field, as evidenced by its impressive Scopus rankings—4th out of 183 in Pharmaceutical Science and 10th out of 313 in Pharmacology, showcasing its high relevance and credibility (98th and 96th percentiles respectively). Researchers, professionals, and students can access a diverse array of articles that encompass groundbreaking studies, reviews, and reports, solidifying the journal's position as a vital resource for anyone engaged in pharmaceutical research. With its commitment to quality and accessibility, Asian Journal of Pharmaceutical Sciences plays an essential role in fostering innovation and collaboration within the global scientific community.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

Nanobiotechnology Reports, an impactful journal published by PLEIADES PUBLISHING INC, serves as a prominent platform for disseminating cutting-edge research at the intersection of nanotechnology and biotechnology. With its ISSN 2635-1676 and E-ISSN 2635-1684, this open-access journal is committed to providing researchers, professionals, and students with accessible knowledge and innovations that drive advancements in this rapidly evolving field. Operating out of the United States, Nanobiotechnology Reports has established itself in various engineering and science categories, including Bioengineering and Biomedical Engineering, currently holding a Q4 quartile ranking in 2023. Although it is in the early stages of its publication journey since its convergence in 2021, the journal aims to foster collaboration and knowledge-sharing within the scientific community, addressing the complexities of nanomaterials and their applications in biological systems. Researchers and practitioners in nanobiotechnology are encouraged to contribute to this expanding body of knowledge, facilitating the development of innovative solutions that impact various sectors, from healthcare to electronics.

Nano-Micro Letters is a premier open-access journal published by Shanghai Jiao Tong University Press, specializing in groundbreaking research in the fields of Electrical and Electronic Engineering, Nanoscience, and Materials Science. Launched in 2009, this journal has rapidly established its reputation, achieving Q1 ranking across various categories, including Electronic, Optical and Magnetic Materials, and Surfaces, Coatings and Films, indicating its significant impact within the academic community. With an impressive Scopus ranking of #5 out of 797 in Electrical and Electronic Engineering and #2 in Surfaces, Coatings and Films, Nano-Micro Letters serves as a vital platform for disseminating cutting-edge insights and innovations in nanotechnology. Researchers, professionals, and students are encouraged to engage with the open-access content, fostering a collaborative environment that promotes the advancement of knowledge in these dynamic fields.

PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION is a distinguished journal dedicated to advancing the knowledge within the fields of Chemistry, Condensed Matter Physics, and Materials Science. Published by WILEY-V C H VERLAG GMBH in Germany, this journal has established a solid reputation since its inception in 1984, showcasing research aimed at understanding the intricate properties and behaviors of particulate systems. With an impressive Q2 ranking in its respective categories and Scopus ranks indicating a robust standing in the global research community, it serves as an essential resource for researchers, professionals, and students. Although it does not currently offer Open Access options, its comprehensive articles and reviews provide valuable insights that contribute significantly to the ongoing discourse in these scientific domains. As it prepares to celebrate four decades of publication, PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION continues to provide a vital platform for emerging knowledge, fostering innovation and collaboration among scientists dedicated to the study of particle systems.

Bioinspired Biomimetic and Nanobiomaterials is a distinguished journal published by Emerald Group Publishing Ltd, focusing on the cutting-edge intersection of biomaterials, engineering, and nanotechnology. Since its inception in 2012, the journal has provided a vital platform for researchers, professionals, and students to disseminate innovative findings that draw inspiration from nature to develop novel biomimetic and bioinspired materials. Although currently indexed in the fourth quartile for Biomaterials and third quartile for miscellaneous Engineering in 2023, the journal is committed to improving its standing and impact by welcoming contributions that exploit the functional capabilities of nanoscale and biomimetic structures. With a strategic aim to foster interdisciplinary collaboration, this journal plays an instrumental role in advancing the field of biomaterials and engineering. Join our community and contribute to shaping the future of sustainable material design and applications.

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

Nanomedicine-Nanotechnology Biology and Medicine is a leading journal published by Elsevier, dedicated to the exploration of innovative applications of nanotechnology in the fields of biology and medicine. With an ISSN of 1549-9634 and an E-ISSN of 1549-9642, this esteemed journal provides a platform for high-quality research, comprehensively covering areas including bioengineering, biomedical engineering, pharmaceutical science, and nanoscience. Notably, it holds a significant position in various categories with a Q2 ranking in multiple disciplines and a prestigious Q1 ranking in Pharmaceutical Science, emphasizing its impact within the scientific community. By facilitating access to cutting-edge studies and advancements, Nanomedicine-Nanotechnology Biology and Medicine serves as an essential resource for researchers, professionals, and students alike, contributing significantly to the ongoing development of nanomedicine and its pivotal role in improving healthcare outcomes. The journal operates without open access; however, it remains committed to disseminating valuable knowledge to a global audience.